Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Karlsson

Showing results (31-40 of 171) with videos related to

Pageof 18
Sort By:
Acta Oncologica (Stockholm, Sweden)|July 10, 2002
Clustering of individuals with both breast and ovarian cancer--a possible indicator of BRCA founder mutationsZakaria Einbeigi, Jeanne M Meis-Kindblom, Lars-Gunnar Kindblom, et al.
Psychiatry Research|November 7, 2006
A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoriaHristina Jovanovic, Asta Cerin, Per Karlsson, et al.
Cancer Medicine|April 20, 2017
Mindfulness and its efficacy for psychological and biological responses in women with breast cancerElisabeth Kenne Sarenmalm, Lena B Mårtensson, Bengt A Andersson, et al.
Scientific Reports|September 16, 2024
A detailed analysis of body composition in relation to cardiopulmonary exercise test indicesPer Karlsson, Robin Strand, Joel Kullberg, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|March 18, 2008
Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal womenMaria Browall, Karin Ahlberg, Per Karlsson, et al.
BMC Cancer|September 10, 2008
Gene expression variation to predict 10-year survival in lymph-node-negative breast cancerElin Karlsson, Ulla Delle, Anna Danielsson, et al.
Acta Oncologica (Stockholm, Sweden)|April 16, 2025
Survival outcomes in hormone receptor-negative breast cancer among BRCA carriers versus noncarriers in western SwedenAnna-Karin Tzikas, Erik Holmberg, Toshima Z Parris, et al.
Breast Cancer Research and Treatment|May 12, 2026
Retrospective study of comparable survival after neoadjuvant versus adjuvant chemotherapy in cT1-2N0M0 triple-negative breast cancerMaxim Olsson, Slavica Janeva, Jari Martikainen, et al.
Human Brain Mapping|October 2, 2010
Extrastriatal dopamine D(2) receptor binding in Huntington's diseaseMouna Esmaeilzadeh, Lars Farde, Per Karlsson, et al.
Cancer Genetics and Cytogenetics|April 6, 2010
High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancerElin Möllerström, Ulla Delle, Anna Danielsson, et al.
Pageof 18

Showing results (31-40 of 171) with videos related to

Sort By:
Pageof 18
Acta Oncologica (Stockholm, Sweden)|July 10, 2002
Clustering of individuals with both breast and ovarian cancer--a possible indicator of BRCA founder mutationsZakaria Einbeigi, Jeanne M Meis-Kindblom, Lars-Gunnar Kindblom, et al.
Psychiatry Research|November 7, 2006
A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoriaHristina Jovanovic, Asta Cerin, Per Karlsson, et al.
Cancer Medicine|April 20, 2017
Mindfulness and its efficacy for psychological and biological responses in women with breast cancerElisabeth Kenne Sarenmalm, Lena B Mårtensson, Bengt A Andersson, et al.
Scientific Reports|September 16, 2024
A detailed analysis of body composition in relation to cardiopulmonary exercise test indicesPer Karlsson, Robin Strand, Joel Kullberg, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|March 18, 2008
Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal womenMaria Browall, Karin Ahlberg, Per Karlsson, et al.
BMC Cancer|September 10, 2008
Gene expression variation to predict 10-year survival in lymph-node-negative breast cancerElin Karlsson, Ulla Delle, Anna Danielsson, et al.
Acta Oncologica (Stockholm, Sweden)|April 16, 2025
Survival outcomes in hormone receptor-negative breast cancer among BRCA carriers versus noncarriers in western SwedenAnna-Karin Tzikas, Erik Holmberg, Toshima Z Parris, et al.
Breast Cancer Research and Treatment|May 12, 2026
Retrospective study of comparable survival after neoadjuvant versus adjuvant chemotherapy in cT1-2N0M0 triple-negative breast cancerMaxim Olsson, Slavica Janeva, Jari Martikainen, et al.
Human Brain Mapping|October 2, 2010
Extrastriatal dopamine D(2) receptor binding in Huntington's diseaseMouna Esmaeilzadeh, Lars Farde, Per Karlsson, et al.
Cancer Genetics and Cytogenetics|April 6, 2010
High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancerElin Möllerström, Ulla Delle, Anna Danielsson, et al.
Pageof 18